Antipsychotics in adolescent-onset psychosis: a work in progress

Lancet Psychiatry. 2017 Aug;4(8):e16-e17. doi: 10.1016/S2215-0366(17)30287-0.

Authors

Anthony C James¹, Matthew R Broome²

Affiliations

¹ Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK.
² Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK; Institute for Mental Health, University of Birmingham, Birmingham, UK. Electronic address: matthew.broome@psych.ox.ac.uk.

PMID: 28748801
DOI: 10.1016/S2215-0366(17)30287-0

No abstract available

MeSH terms

Adolescent
Antipsychotic Agents / adverse effects
Antipsychotic Agents / therapeutic use*
Child
Humans
Psychotic Disorders / drug therapy*
Randomized Controlled Trials as Topic
Schizophrenia / drug therapy*
Treatment Outcome

Substances

Antipsychotic Agents